Updated results of phase I study of trastuzumab deruxtecan (DS-8201a) in HER2-expressing advanced colorectal cancer Meeting Abstract

  

Authors:	Yoshino, T.; Iwata, H.; Tamura, K.; Takahashi, S.; Redfern, C.; Modi, S.; Doi, T.; Kawakami, H.; Taniguchi, H.; Takashima, A.; Yamaguchi, K.; Fisher, J.; Li, B.; Saito, K.; Fujisaki, Y.; Sugihara, M.; Tsurutani, J.
Abstract Title:	Updated results of phase I study of trastuzumab deruxtecan (DS-8201a) in HER2-expressing advanced colorectal cancer
Meeting Title:	43rd ESMO Congress (ESMO 2018)
Journal Title:	Annals of Oncology
Volume:	29
Issue:	Suppl. 8
Meeting Dates:	2018 Oct 19-23
Meeting Location:	Munich, Germany
ISSN:	0923-7534
Publisher:	Oxford University Press
Date Published:	2018-10-01
Start Page:	mdy281.109
Language:	English
ACCESSION:	WOS:000459277301144
PROVIDER:	wos
DOI:	10.1093/annonc/mdy281.109
Notes:	Meeting Abstract: 563P -- Appears on page viii188 of the abstract book -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/145115